10.08.2011 • News

Symrise H1 Profit Decline

Symrise reported a drop in its first-half net income to €77.4 million from €88.8 million last year. This corresponds to earnings per share of €0.65 for the recent period versus €0.75 a year earlier.

However, in the first six months of the current financial year, Symrise posted an increase in group revenues of about 2 % to €811.8 million from €797.5 million in the previous year. The sales increase was 2.6% at local currency.

The company added that during the first half, Symrise's earnings picture was mainly affected by high raw material costs and currency effects. For 2011, Symrise said it continues to target an EBITDA margin of around 20%.

 

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read